Methods for isolating crystalline form I of 5-azacytidine
US8481715B2 · kind B2 · utility
2Cited by
25References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 5, 2012 |
| Grant date | Jul 9, 2013 |
| Priority date | — |
| Expiry date | Jun 5, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H19/12
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The invention includes methods for isolating crystalline Form I of 5-azacytidine substantially free of other forms, wherein 5-azacytidine is represented by the formula:The invention also includes pharmaceutical compositions comprising Form I of 5-azacytidine.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.